|
1
|
Salah Z, Arafeh R, Maximov V, Galasso M,
Khawaled S, Abou-Sharieha S, Volinia S, Jones KB, Croce CM and
Aqeilan RI: miR-27a and miR-27a* contribute to metastatic
properties of osteosarcoma cells. Oncotarget. 6:4920–4935. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Han G, Wang Y and Bi W: C-Myc
overexpression promotes osteosarcoma cell invasion via activation
of MEK-ERK pathway. Oncol Res. 20:149–156. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tang J, Shen L, Yang Q and Zhang C:
Overexpression of metadherin mediates metastasis of osteosarcoma by
regulating epithelial-mesenchymal transition. Cell Prolif.
47:427–434. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shang Y, Wang LQ, Guo QY and Shi TL:
MicroRNA-196a overexpression promotes cell proliferation and
inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway. Int J Clin
Exp Pathol. 8:2461–2472. 2015.PubMed/NCBI
|
|
5
|
Liu Y, Li Y, Liu J, Wu Y and Zhu Q:
MicroRNA-132 inhibits cell growth and metastasis in osteosarcoma
cell lines possibly by targeting Sox4. Int J Oncol. 47:1672–1684.
2015.PubMed/NCBI
|
|
6
|
Gorlick R: Current concepts on the
molecular biology of osteosarcoma. Cancer Treat Res. 152:467–478.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Meyers PA: Muramyl tripeptide
(mifamurtide) for the treatment of osteosarcoma. Expert Rev
Anticancer Ther. 9:1035–1049. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Marina N, Gebhardt M, Teot L and Gorlick
R: Biology and therapeutic advances for pediatric osteosarcoma.
Oncologist. 9:422–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ameres SL and Zamore PD: Diversifying
microRNA sequence and function. Nat Rev Mol Cell Biol. 14:475–488.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun K and Lai EC: Adult-specific functions
of animal microRNAs. Nat Rev Genet. 14:535–548. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tahara H, Kay MA, Yasui W and Tahara E:
MicroRNAs in cancer: The 22nd Hiroshima cancer seminar/the 4th
Japanese Association for RNA Interference Joint International
Symposium, 30 August 2012, Grand Prince Hotel Hiroshima. Jpn J Clin
Oncol. 43:579–582. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yates LA, Norbury CJ and Gilbert RJ: The
long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kasinski AL and Slack FJ: Epigenetics and
genetics. MicroRNAs en route to the clinic: Progress in validating
and targeting microRNAs for cancer therapy. Nat Rev Cancer.
11:849–864. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen CZ: MicroRNAs as oncogenes and tumor
suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Caldas C and Brenton JD: Sizing up miRNAs
as cancer genes. Nat Med. 11:712–714. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Namlos HM, Meza-Zepeda LA, Barøy T,
Østensen IH, Kresse SH, Kuijjer ML, Serra M, Bürger H,
Cleton-Jansen AM and Myklebost O: Modulation of the osteosarcoma
expression phenotype by microRNAs. PLoS One. 7:e480862012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang XH, Cai P, Wang MH and Wang Z:
microRNA25 promotes osteosarcoma cell proliferation by targeting
the cell-cycle inhibitor p27. Mol Med Rep. 10:855–859.
2014.PubMed/NCBI
|
|
19
|
Zhuo W, Ge W, Meng G, Jia S, Zhou X and
Liu J: MicroRNA20a promotes the proliferation and cell cycle of
human osteosarcoma cells by suppressing early growth response 2
expression. Mol Med Rep. 12:4989–4994. 2015.PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gu R, Sun YF, Wu MF, Liu JB, Jiang JL,
Wang SH, Wang XL and Guo Q: Biological roles of microRNA-140 in
tumor growth, migration, and metastasis of osteosarcoma in vivo and
in vitro. Tumour Biol. 37:353–360. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li B, Huang P, Qiu J, Liao Y, Hong J and
Yuan Y: MicroRNA-130a is down-regulated in hepatocellular carcinoma
and associates with poor prognosis. Med Oncol. 31:2302014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Boll K, Reiche K, Kasack K, Mörbt N,
Kretzschmar AK, Tomm JM, Verhaegh G, Schalken J, von Bergen M, Horn
F and Hackermüller J: MiR-130a, miR-203 and miR-205 jointly repress
key oncogenic pathways and are downregulated in prostate carcinoma.
Oncogene. 32:277–285. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pan Y, Wang R, Zhang F, Chen Y, Lv Q, Long
G and Yang K: MicroRNA-130a inhibits cell proliferation, invasion
and migration in human breast cancer by targeting the RAB5A. Int J
Clin Exp Pathol. 8:384–393. 2015.PubMed/NCBI
|
|
26
|
Jiang H, Yu WW, Wang LL and Peng Y:
miR-130a acts as a potential diagnostic biomarker and promotes
gastric cancer migration, invasion and proliferation by targeting
RUNX3. Oncol Rep. 34:1153–1161. 2015.PubMed/NCBI
|
|
27
|
Yang LY, Wang HJ, Jia XB, Wang X, Luo J
and Zhang XY: Expression of miR-130a in cisplatin resistant cell
lines of ovarian cancer. Sichuan Da Xue Xue Bao Yi Xue Ban.
43:60–64. 2012.(In Chinese). PubMed/NCBI
|
|
28
|
Zhou YM, Liu J and Sun W: MiR-130a
overcomes gefitinib resistance by targeting met in non-small cell
lung cancer cell lines. Asian Pac J Cancer Prev. 15:1391–1396.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang J, Wu H, Li P, Zhao Y, Liu M and
Tang H: NF-kB-modulated miR-130a targets TNF-α in cervical cancer
cells. J Transl Med. 12:1552014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee SH, Jung YD, Choi YS and Lee YM:
Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases
cell proliferation and tumor angiogenesis in gastric cancer cells.
Oncotarget. 6:33269–33278. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu X, Liu Y, Wu S, Shi X, Li L, Zhao J
and Xu H: Tumor-suppressing effects of miR-429 on human
osteosarcoma. Cell Biochem Biophys. 70:215–224. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shen A, Zhang Y, Yang H, Xu R and Huang G:
Overexpression of ZEB1 relates to metastasis and invasion in
osteosarcoma. J Surg Oncol. 105:830–834. 2012. View Article : Google Scholar : PubMed/NCBI
|
